title: Amgen spikes interest in live virus vaccines for hard-to-treat cancers.
authors.forename: Charlie
authors.initials: C
authors.lastname: Schmidt
mesh_terms: D019496:Cancer Vaccines / Q000276:immunology* / Q000494:pharmacology; D006801:Humans; D050130:Oncolytic Virotherapy / Q000379:methods*; D050504:Oncolytic Viruses / Q000378:metabolism; D014613:Vaccines, Attenuated / Q000276:immunology / Q000494:pharmacology
chemical_list: D019496:Cancer Vaccines; D014613:Vaccines, Attenuated